"Infertility treatment heads first drugs on FDA’s new priority review scheme" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Oct. 19, GNA-The Food and Drugs Authority (FDA) has suspended the operations of nine sachet water producers in the Western North ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday.

The Trump administration struck a deal with EMD Serono, the health care business of Merck KGaA in the United States and ...

The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

The Commissioner’s National Priority Voucher awards companies that align with specific national priorities—such as boosting ...

The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at the agency ...

The Trump administration has struck a deal with EMD Serono to lower drug prices — part of a larger push from the ...

The Food and Drugs Authority (FDA) has organised training on Good Manufacturing Practices (GMP) for food manufacturing industries to ...

Novo Nordisk's Bloomington facility received an OAI label from the FDA due to compliance issues, including contamination by ...